Aspen Neuroscience, Inc. (ASPE)
NASDAQ
ASPE price, last 12 months
Key stats
- Previous close
- $12.01
- Open
- $12.15
- Day range
- $12.00 – $13.10
- 52-week range
- $11.20 – $14.90
- Volume
- 289.3K
- Avg volume (20 days)
- —
- Market cap
- $366.1M
Performance
Technicals and fundamentals
About Aspen Neuroscience, Inc.
Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.
- Listed on
- NASDAQ
- Market cap
- $366.1M